RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerCristina Cruz, Violeta Serra, Orland Dı́ez et al.|Annals of Oncology|2018Cited by 424
Enhancing global access to cancer medicinesJavier Cortés, Joaquı́n Arribas, José Manuel Pérez-García et al.|CA A Cancer Journal for Clinicians|2020Cited by 205
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulationEnrique J. Arenas, Joaquı́n Arribas|Nature Communications|2021Cited by 56
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast CancerSantiago Duro‐Sánchez, Joaquı́n Arribas|Cancer Research|2022Cited by 41
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Clinical Cancer Research|2022Cited by 22